CCR’s Douglas Lowy and John Schiller receive the 2017 Lasker~DeBakey Clinical Medical Research Award


Drs. Douglas Lowy and John Schiller

Douglas Lowy, M.D., Chief of the Laboratory of Cellular Oncology, and John Schiller, Ph.D., Deputy Chief of the Laboratory of Cellular Oncology have received the 2017 Lasker~DeBakey Clinical Medical Research Award for their groundbreaking research leading to the development of human papillomavirus (HPV) vaccines. The Lasker Awards are widely regarded as the country’s most prestigious biomedical research prizes and have recognized outstanding basic and clinical medical research since 1945.

Given the high incidence of HPV-related cancers worldwide, the research of Drs. Lowy and Schiller has had an immense public health impact, improving the lives of many thousands of people through cancer prevention. Three preventive HPV vaccines have been approved by the U.S. Food and Drug Administration as a result of their remarkable efforts to understand HPV infection.

The duo’s groundbreaking work was made possible through publicly supported research. Lowy and Schiller credit the enabling environment of the NCI intramural program, where scientists can do long-term, high-risk research, as integral to their success.

More information is available in the NCI press release.  The 2017 Lasker Awards will be presented on September 15 in New York City. 

Summary Posted: 09/2017